innovation needed

From an article in the pharma times about unsustainability of current pharma models.
The wide spread lowering drug prices are reducing the diversity of products on the market and big pharmas are primarily protecting their successful patents rather than investing into innovation.

In this global struggle for innovation, our technology contributes to both ends of the spectrum, namely lowering medication dosages as delivery is up to 10 times improved compared to existing deliveries, as well as providing self applied and controlled delivery which reduces healthcare costs on a broad level.


Worldwide, there is now a lack of public health-driven medical innovation and access to essential medicines, while at the same time, governments are no longer capable of facing the growing costs of health care, of which medicine prices are an important factor. Therefore, new models of affordable and socially-useful medical innovation are needed, said the organisers.

http://www.pharmatimes.com/Article/10-11-23/Current_pharma_model_is_no_longer_affordable_MEPs_told.aspx


These European news further intensify the need for global pharmaceutical companies to innovate without high cost development risks.
Our patch is not only highly competitive in its delivery
ratios, it is also cheap to produce, particularly with 3M guaranteeing the highest quality standard worldwide.